Morgan Stanley analyst Kallum Titchmarsh lowered the firm's price target on Thermo Fisher to $620 from $670 and keeps an Overweight rating on the shares. Investors "were clearly looking for more" this quarter, says the analyst, who makes "modest updates" to the firm's model following the Q1 report in light of guidance.
